Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Lintzeris

Showing results (131-140 of 196) with videos related to

Pageof 20
Sort By:
BMJ Sexual & Reproductive Health|March 12, 2024
Interconnections between unintended pregnancy, alcohol and other drug use, and pregnancy, birth, infant, childhood and socioeconomic outcomes: a scoping reviewKelly A McNamara, Bridin Murnion, Penelope Fotheringham, et al.
Drug and Alcohol Dependence|September 11, 2013
Exercise increases plasma THC concentrations in regular cannabis usersAlexander Wong, Mark E Montebello, Melissa M Norberg, et al.
Pain Medicine (Malden, Mass.)|May 16, 2018
Concerns and Help-Seeking Among Patients Using Opioids for Management of Chronic Noncancer PainBriony Larance, Gabrielle Campbell, Teleri Moore, et al.
Pain|March 11, 2016
Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients?Gabrielle Campbell, Raimondo Bruno, Nicholas Lintzeris, et al.
Drug and Alcohol Dependence|March 22, 2022
Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trialMark Montebello, Meryem Jefferies, Llewellyn Mills, et al.
Drug and Alcohol Dependence|December 30, 2015
Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scaleBriony Larance, Raimondo Bruno, Nicholas Lintzeris, et al.
Journal of Addiction Medicine|December 3, 2024
Methadone-Buprenorphine Transfers Using Low Dosing of Buprenorphine: An Open-label, Nonrandomized Clinical TrialChris Tremonti, James Blogg, Nazila Jamshidi, et al.
Drug and Alcohol Review|February 11, 2026
Risk Factors for Cognitive Impairment in Adults Attending Australian Community-Based Substance Use Treatment ServicesNicole Ridley, Ashley Wheeler, Heather M Francis, et al.
Addiction (Abingdon, England)|September 25, 2014
Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT)Nicola Metrebian, Teodora Groshkova, Jennifer Hellier, et al.
BMJ Open|August 2, 2020
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB studyBriony Larance, Marianne Byrne, Nicholas Lintzeris, et al.
Pageof 20

Showing results (131-140 of 196) with videos related to

Sort By:
Pageof 20
BMJ Sexual & Reproductive Health|March 12, 2024
Interconnections between unintended pregnancy, alcohol and other drug use, and pregnancy, birth, infant, childhood and socioeconomic outcomes: a scoping reviewKelly A McNamara, Bridin Murnion, Penelope Fotheringham, et al.
Drug and Alcohol Dependence|September 11, 2013
Exercise increases plasma THC concentrations in regular cannabis usersAlexander Wong, Mark E Montebello, Melissa M Norberg, et al.
Pain Medicine (Malden, Mass.)|May 16, 2018
Concerns and Help-Seeking Among Patients Using Opioids for Management of Chronic Noncancer PainBriony Larance, Gabrielle Campbell, Teleri Moore, et al.
Pain|March 11, 2016
Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients?Gabrielle Campbell, Raimondo Bruno, Nicholas Lintzeris, et al.
Drug and Alcohol Dependence|March 22, 2022
Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trialMark Montebello, Meryem Jefferies, Llewellyn Mills, et al.
Drug and Alcohol Dependence|December 30, 2015
Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scaleBriony Larance, Raimondo Bruno, Nicholas Lintzeris, et al.
Journal of Addiction Medicine|December 3, 2024
Methadone-Buprenorphine Transfers Using Low Dosing of Buprenorphine: An Open-label, Nonrandomized Clinical TrialChris Tremonti, James Blogg, Nazila Jamshidi, et al.
Drug and Alcohol Review|February 11, 2026
Risk Factors for Cognitive Impairment in Adults Attending Australian Community-Based Substance Use Treatment ServicesNicole Ridley, Ashley Wheeler, Heather M Francis, et al.
Addiction (Abingdon, England)|September 25, 2014
Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT)Nicola Metrebian, Teodora Groshkova, Jennifer Hellier, et al.
BMJ Open|August 2, 2020
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB studyBriony Larance, Marianne Byrne, Nicholas Lintzeris, et al.
Pageof 20